194 related articles for article (PubMed ID: 16336420)
41. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
[TBL] [Abstract][Full Text] [Related]
42. Primary prevention of cardiovascular disease in people with dysglycemia.
Bianchi C; Miccoli R; Penno G; Del Prato S
Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
[TBL] [Abstract][Full Text] [Related]
43. Metabolic characteristics of glucose intolerance: the critical role of obesity.
Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
[TBL] [Abstract][Full Text] [Related]
44. Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study.
Vambergue A; Dognin C; Boulogne A; Réjou MC; Biausque S; Fontaine P
Diabet Med; 2008 Jan; 25(1):58-64. PubMed ID: 18028442
[TBL] [Abstract][Full Text] [Related]
45. Should oral glucose tolerance testing be mandatory following acute myocardial infarction?
Jessani S; Gangopadhyay K; Patel JV; Lip GY; Millane T
Int J Clin Pract; 2007 Apr; 61(4):680-3. PubMed ID: 17394440
[TBL] [Abstract][Full Text] [Related]
46. [Impaired glucose tolerance (IGT): current understanding and future research directions].
Terauchi Y; Kadowaki T
Nihon Rinsho; 2005 Feb; 63 Suppl 2():21-6. PubMed ID: 15779340
[No Abstract] [Full Text] [Related]
47. Diabetes and impaired glucose tolerance: a review of the epidemiological and trial evidence for their role in cardiovascular risk.
Bowman L; Armitage J
Semin Vasc Med; 2002 Nov; 2(4):383-9. PubMed ID: 16222628
[TBL] [Abstract][Full Text] [Related]
48. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.
Cnop M; Vidal J; Hull RL; Utzschneider KM; Carr DB; Schraw T; Scherer PE; Boyko EJ; Fujimoto WY; Kahn SE
Diabetes Care; 2007 Mar; 30(3):677-82. PubMed ID: 17327340
[TBL] [Abstract][Full Text] [Related]
49. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
[TBL] [Abstract][Full Text] [Related]
50. Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.
Gamberini MR; Fortini M; De Sanctis V; Gilli G; Testa MR
Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():285-91. PubMed ID: 16462713
[TBL] [Abstract][Full Text] [Related]
51. Post-challenge hyperglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events.
Gao W; Qiao Q; Tuomilehto J
Clin Lab; 2004; 50(9-10):609-15. PubMed ID: 15481637
[TBL] [Abstract][Full Text] [Related]
52. Lifestyle intervention in individuals with normal versus impaired glucose tolerance.
Schäfer S; Kantartzis K; Machann J; Venter C; Niess A; Schick F; Machicao F; Häring HU; Fritsche A; Stefan N
Eur J Clin Invest; 2007 Jul; 37(7):535-43. PubMed ID: 17576204
[TBL] [Abstract][Full Text] [Related]
53. Impaired glucose tolerance and cardiovascular disease: the possible role of post-prandial hyperglycemia.
Ceriello A
Am Heart J; 2004 May; 147(5):803-7. PubMed ID: 15131534
[TBL] [Abstract][Full Text] [Related]
54. [Postprandial hyperglycemia and diabetic complications].
Da Ros R; Assaloni R; Ceriello A
Recenti Prog Med; 2005 Sep; 96(9):436-44. PubMed ID: 16229326
[TBL] [Abstract][Full Text] [Related]
55. [The cardiovascular risk profile in patients with disorders of glucose tolerance (borderline diabetes) dependent on the heredity of the diabetes].
Schneider H; Ziegelasch HJ
Z Gesamte Inn Med; 1981 Apr; 36(7):241-3. PubMed ID: 7281825
[TBL] [Abstract][Full Text] [Related]
56. [Role of insulin resistance in diabetes mellitus and other risk factors for cardiovascular diseases].
Tack CJ; Smits P; Lutterman JA
Ned Tijdschr Geneeskd; 1992 Aug; 136(35):1697-701. PubMed ID: 1407112
[No Abstract] [Full Text] [Related]
57. Inflammation and cardiovascular disease in patients with diabetes: lessons from the Diabetes Control and Complications Trial.
Festa A; Haffner SM
Circulation; 2005 May; 111(19):2414-5. PubMed ID: 15897355
[No Abstract] [Full Text] [Related]
58. Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations.
Giles TD; Sander GE
Cardiol Clin; 2004 Nov; 22(4):553-68. PubMed ID: 15501623
[TBL] [Abstract][Full Text] [Related]
59. Diabetes mellitus and cardiovascular complications: pathophysiological peculiarities and therapeutic implications.
Modena MG; Barbieri A
Cardiologia; 1999 Oct; 44(10):865-77. PubMed ID: 10630046
[TBL] [Abstract][Full Text] [Related]
60. Impaired glucose tolerance and future cardiovascular risk after coronary revascularization: a 10-year follow-up report.
Tsuchida K; Mitsuma W; Sato Y; Ozaki K; Soda S; Hatada K; Tanaka K; Hosaka Y; Imai S; Takahashi K; Matsubara T; Oda H
Acta Diabetol; 2020 Feb; 57(2):173-182. PubMed ID: 31375898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
